Using cohort studies to estimate mortality among injecting drug users that is not attributable to AIDS

Degenhardt, L.; Hall, W..; Warner-Smith, M.
June 2006
Sexually Transmitted Infections;Jun2006 Supplement III, Vol. 82, piii56
Academic Journal
Background: Injecting drug use (IDU) and associated mortality appear to be increasing in many parts of the world. IDU is an important factor in HIV transmission. In estimating AIDS mortality attributable to IDU, it is important to take account of premature mortality rates from other causes to ensure that AIDS related mortality among injecting drug users (IDUs) is not overestimated. The current review provides estimates of the excess non-AIDS mortality among IDUs. Method: Searches were conducted with Medline, PsycINFO, and the Web of Science. The authors also searched reference lists of identified papers and an earlier literature review by English et al (1995). Crude mortalily rates (CMRs) were derived from data on the number of deaths, period of follow up, and number of participants. In estimating the all-cause mortality, two rates were calculated: one that included all cohort studies identified in the search, and one that only included studies that reported on AIDS deaths in their cohort. This provided lower and upper mortality rates, respectively. Results: The current paper derived weighted mortality rates based upon cohort studies that included 179 885 participants, 1 219 422 person-years of observation, and 16 593 deaths. The weighted crude AIDS mortality rate from studies that reported AIDS deaths was approximately 0.78% per annum. The median estimated non-AIDS mortalily rate was 1.08% per annum. Conclusions: Illicit drug users have a greatly increased risk of premature death and mortality due to AIDS forms a significant part of that increased risk; it is, however, only part of that risk. Future work needs to examine mortality rates among IDUs in developing countries, and collect data on the relation between HIV and increased mortality due to all causes among this group.


Related Articles

  • Transmission of HIV from injecting drug users to their wives in India. Panda, S.; Chatterjee, A.; Bhattacharya, S. K.; Manna, B.; Singh, P. N.; Sarkar, S.; Naik, T. N.; Chakrabarti, S.; Detels, R. // International Journal of STD & AIDS;Jul2000, Vol. 11 Issue 7, p468 

    We aimed to identify factors associated with transmission of human immunodeficiency virus (HIV) from injecting drug users (IDUs) to their wives in Manipur, northeast India, where the prevalence of HIV among IDUs is 80% via a case-control study. One hundred and sixty-one HIV-infected IDUs and...

  • New report says needle exchanges do not increase IV drug use.  // Nation's Health;Nov95, Vol. 25 Issue 10, p1 

    Reports that the needle-exchange programs in reducing the spread of HIV do not increase intravenous (IV) drug use. September 1995 release of report titled, `Preventing HIV Transmission: The Role of Sterile Needles and Bleach,' by a joint panel; 1993 creation of the panel to investigate the...

  • Heterosexual transmission of HIV in injecting drug users. Ronald, Peter J.M.; Robertson, J.R.; Wyld, R.; Weightman, R. // BMJ: British Medical Journal (International Edition);11/6/93, Vol. 307 Issue 6913, p1184 

    Investigates the heterosexual transmission of HIV in injecting drug users. Prevalence of HIV infection among injecting drug users; Reduction of high risk behaviors; Suggestions for the increased awareness of the risks of infection.

  • Global AIDS surveillance.  // Weekly Epidemiological Record;12/14/2001, Vol. 76 Issue 50, p390 

    Presents an analysis of the distribution of reported AIDS cases by age and sex and by assumed mode of transmissions. Total number of officially reported AIDS cases; High burden of HIV-related illnesses in many African countries; Decline in cases related to intravenous drug use.

  • HIV Infection in Intravenous Drug Users Entering Drug Treatment, United States, 1988 to 1989. Allen, David M.; Onorato, Ida M.; Green, Timothy A. // American Journal of Public Health;Apr92, Vol. 82 Issue 4, p541 

    Background. Intravenous drug use has played a key role in the human immunodeficiency virus (HIV) epidemic. Standardized surveillance of HIV infection among intravenous drug user (IVDUs) is needed to determine HIV prevalence, rates, to monitor changes in prevalence rates, to monitor changes in...

  • Clinical features of drug use and drug use related HIV. Brettle, R. P. // International Journal of STD & AIDS;May1996, Vol. 7 Issue 3, p151 

    A variety of important medical problems, both non-infective and infective in nature, are associated with drug use. A number of micro-organisms are associated with the non-sterile nature of injection drug use (IDU) whilst a number of blood borne viruses, including retroviruses such as HIV, are...

  • NEPs remain public health priority despite federal funding ban. Shafer, Emily // Infectious Disease News;Dec2013, Vol. 26 Issue 12, p1 

    The article reports on developments related to needle exchange programs (NEP) as a means of reducing the transmission of the human immunodeficiency virus (HIV) among injection drug users in the U.S. as of December 2013.

  • Prevalence of HIV and injecting drug use in men entering Liverpool prison. Bellis, Mark A.; Weild, Andrew R. // BMJ: British Medical Journal (International Edition);07/05/97, Vol. 315 Issue 7099, p30 

    Examines the potential role of English prisons in drug related transmission of HIV and other bloodborn viruses among prisoners in England. History of injecting drug use before imprisonment; Percentage of newly incarcerated people who continue to inject drugs.

  • Syringe Prescription to Prevent HIV Infection in Rhode Island: A Case Study. Rich, Josiah D.; Macalino, Grace E.; McKenzie, Michelle; Taylor, Lynn E.; Burris, Scott // American Journal of Public Health;May2001, Vol. 91 Issue 5, p699 

    Because of the illicit nature of drug use, a tremendous amount of mistrust and fear on the part of IDUs often leads to poor interaction with the medical establishment. Prescription of syringes by a physician can serve as a tool for reaching out to a high-risk and often out-of-treatment...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics